## **Core Concept**
The question pertains to the histological patterns of endometrial cancer (Ca endometrium) and their prognostic implications. Endometrial cancer is primarily classified into two types based on histology, molecular features, and clinical behavior: Type I (endometrioid adenocarcinoma) and Type II (non-endometrioid adenocarcinoma, including serous, clear cell, and others). The prognosis varies significantly among these types.
## **Why the Correct Answer is Right**
The correct answer, **serous adenocarcinoma**, has the worst prognosis among the listed histological patterns of endometrial cancer. Serous adenocarcinoma is a subtype of Type II endometrial cancer, known for its aggressive behavior, high grade, and tendency to present at an advanced stage. It accounts for about 10% of endometrial cancers but is responsible for a disproportionate number of deaths due to its aggressive nature and resistance to conventional therapies.
## **Why Each Wrong Option is Incorrect**
- **Option A (Endometrioid adenocarcinoma):** This is the most common type of endometrial cancer, usually having a better prognosis compared to serous adenocarcinoma, especially when detected early. It is often associated with estrogen exposure.
- **Option B (Mucinous adenocarcinoma):** This is a rare subtype of endometrial cancer with a generally favorable prognosis, similar to or slightly worse than endometrioid adenocarcinoma.
- **Option C (Clear cell adenocarcinoma):** Although it has a worse prognosis than endometrioid adenocarcinoma, clear cell carcinoma tends to have a slightly better prognosis than serous adenocarcinoma.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **serous adenocarcinoma of the endometrium** is often associated with **TP53 mutations**, which contribute to its aggressive behavior and poor prognosis. This subtype requires prompt and aggressive treatment.
## **Correct Answer:** . Serous adenocarcinoma
Free Medical MCQs Β· NEET PG Β· USMLE Β· AIIMS
Access thousands of free MCQs, ebooks and daily exams.
By signing in you agree to our Privacy Policy.